Biogen Inc.

Contributing Author

Recent Articles by Biogen Inc.

Jul-10	Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress BIIB GlobeNewswire
Jun-30	Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous Nephropathy BIIB GlobeNewswire
Jun-27	New Data for Nusinersen Underscore Biogen's Commitment to Advancing Clinical Research to Improve Outcomes in SMA BIIB GlobeNewswire
Jun-25	Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results BIIB GlobeNewswire
Jun-18	Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia BIIB GlobeNewswire
Jun-12	Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity BIIB GlobeNewswire
May-27	Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies BIIB GlobeNewswire